Regenerative Medicine For Cartilage Global Market Report 2022 – By Treatment Modality (Cell-Based, Non-Cell-Based), By Treatment Type (Palliative, Intrinsic Repair Stimulus), By Site ( Knee Cartilage Repair, Ribs), By Application (Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration), By End-Use (Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers )– Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 150 | Published : February 2022 | SKU CODE : h036 | Delivery Time: 2-3 business days | Format :


The regenerative medicine for cartilage market consists of sales of regenerative medicines for the cartilage by entities (organizations, sole traders, and partnerships) that have the capacity to grow muscles and organs in the lab and safely implant them when the body cannot regenerate itself, as observed for cartilage tissue after injury or wear. Only goods and services traded between entities or sold to end consumers are included.

 

The main types of treatments in regenerative medicine for cartilage market are palliative, intrinsic repair stimulus, others. Palliative care is an interdisciplinary medical method to helping patients with serious, complex illnesses improve their quality of life and reduce their suffering. The different types of treatment modality are cell-based, non-cell-based and involves various sites such as knee cartilage repair, ribs, others. It is used in hyaline cartilage repair and regeneration, elastic cartilage repair and regeneration, fibrous cartilage repair and regeneration and is implemented in various sectors such as ambulatory surgical centers, hospitals & clinics, surgical centers, others.  

 

The global regenerative medicine for cartilage market size is expected to grow from $4.83 billion in 2021 to $5.26 billion in 2022 at a compound annual growth rate (CAGR) of 9%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The regenerative medicine for cartilage market is expected to reach $7.03 billion in 2026 at a CAGR of 7.5%.

 

The growing incidence of osteoarthritis across the globe will drive the market for regenerative medicine for cartilage market. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation in 2019, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for the cartilage regenerative medicine market.

 

The high cost of regenerative medicine therapies is one of the major factors limiting the growth of the market for regenerative medicine for cartilage. The average cost for knee replacement is around $4,500 to $8,400, while the average cost of cartilage repair procedures is around $18,000, depending on the country where the procedure is being performed. Such high prices discourage individuals to resort to cartilage repair therapies, and in turn, result in a lower preference for these procedures.

 

Tissue engineering and stem cell therapy are emerging trends in the regenerative medicine for cartilage market. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair. For instance, growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively. Companies operating in the market are continuously focusing on introducing new technologies to survive in the regenerative medicine for cartilage market.

 

In April 2019, Smith & Nephew plc, a UK-based multinational medical equipment manufacturing company, acquired Osiris Therapeutics, Inc. for approximately $660 million. The acquisition is expected to stimulate growth from Smith & Nephew’s advanced wound management franchise. Osiris Therapeutics, Inc. is a US-based company that researches and develops therapeutic products for the regeneration of human connective tissues.  

 

Major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies and CellGenix.  

 

Europe was the largest region in regenerative medicine for cartilage market in 2021. The regions covered in the regenerative medicine for cartilage market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

 

The countries covered in the regenerative medicine for cartilage market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

 

The global regenerative medicine for cartilage market is segmented -

1) By Treatment Modality: Cell-Based, Non-Cell-Based

 

2) By Treatment Type: Palliative, Intrinsic Repair Stimulus, Others

 

3) By Site: Knee Cartilage Repair, Ribs, Others

 

4) By Application: Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration

 

5) By End-User: Ambulatory Surgical Centers, Hospitals and Clinics, Surgical Centers, Others

    Table Of Contents

    1. Executive Summary

    2. Regenerative Medicine For Cartilage

    Market Characteristics

    3. Regenerative Medicine For Cartilage

    Market Trends And Strategies

    4. Impact Of COVID-19 On Regenerative Medicine For Cartilage

    5. Regenerative Medicine For Cartilage

    Market Size And Growth

    5.1. Global Regenerative Medicine For Cartilage

    Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Regenerative Medicine For Cartilage

    Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Regenerative Medicine For Cartilage

    Market Segmentation

    6.1. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Modality, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Cell-Based

    Non-Cell-Based

    6.2. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Palliative

    Intrinsic Repair Stimulus

    Others

    6.3. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Site, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Knee Cartilage Repair

    Ribs

    Others

    6.4. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hyaline Cartilage Repair and Regeneration

    Elastic Cartilage Repair and Regeneration

    Fibrous Cartilage Repair and Regeneration

    6.5. Global Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Ambulatory Surgical Centers

    Hospitals & Clinics

    Surgical Centers

    Others

    7. Regenerative Medicine For Cartilage

    Market Regional And Country Analysis

    7.1. Global Regenerative Medicine For Cartilage

    Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Regenerative Medicine For Cartilage

    Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Regenerative Medicine For Cartilage

    Market

    8.1. Asia-Pacific Regenerative Medicine For Cartilage

    Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Regenerative Medicine For Cartilage

    Market

    9.1. China Regenerative Medicine For Cartilage

    Market Overview

    9.2. China Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Regenerative Medicine For Cartilage

    Market

    10.1. India Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Regenerative Medicine For Cartilage

    Market

    11.1. Japan Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Regenerative Medicine For Cartilage

    Market

    12.1. Australia Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Regenerative Medicine For Cartilage

    Market

    13.1. Indonesia Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Regenerative Medicine For Cartilage

    Market

    14.1. South Korea Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Regenerative Medicine For Cartilage

    Market

    15.1. Western Europe Regenerative Medicine For Cartilage

    Market Overview

    15.2. Western Europe Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Regenerative Medicine For Cartilage

    Market

    16.1. UK Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Regenerative Medicine For Cartilage

    Market

    17.1. Germany Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Regenerative Medicine For Cartilage

    Market

    18.4. France Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Regenerative Medicine For Cartilage

    Market

    19.1. Eastern Europe Regenerative Medicine For Cartilage

    Market Overview

    19.2. Eastern Europe Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Regenerative Medicine For Cartilage

    Market

    20.1. Russia Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Regenerative Medicine For Cartilage

    Market

    21.1. North America Regenerative Medicine For Cartilage

    Market Overview

    21.2. North America Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Regenerative Medicine For Cartilage

    Market

    22.1. USA Regenerative Medicine For Cartilage

    Market Overview

    22.2. USA Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Regenerative Medicine For Cartilage

    Market

    23.1. South America Regenerative Medicine For Cartilage

    Market Overview

    23.2. South America Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Regenerative Medicine For Cartilage

    Market

    24.1. Brazil Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Regenerative Medicine For Cartilage

    Market

    25.1. Middle East Regenerative Medicine For Cartilage

    Market Overview

    25.2. Middle East Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Regenerative Medicine For Cartilage

    Market

    26.1. Africa Regenerative Medicine For Cartilage

    Market Overview

    26.2. Africa Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Regenerative Medicine For Cartilage

    Market Competitive Landscape And Company Profiles

    27.1. Regenerative Medicine For Cartilage

    Market Competitive Landscape

    27.2. Regenerative Medicine For Cartilage

    Market Company Profiles

    27.2.1. B. Braun Melsungen AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Zimmer Biomet Holdings Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Vericel Corporation

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Stryker Corporation

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Smith & Nephew plc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Regenerative Medicine For Cartilage

    Market

    29. Regenerative Medicine For Cartilage

    Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Modality, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Site, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Regenerative Medicine For Cartilage
  • Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Global Regenerative Medicine For Cartilage
  • Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 47: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 48: B. Braun Melsungen AG Financial Performance
  • Table 49: Zimmer Biomet Holdings Inc. Financial Performance
  • Table 50: Vericel Corporation Financial Performance
  • Table 51: Stryker Corporation Financial Performance
  • Table 52: Smith & Nephew plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Modality, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Site, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Regenerative Medicine For Cartilage
  • Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Global Regenerative Medicine For Cartilage
  • Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 47: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 48: B. Braun Melsungen AG Financial Performance
  • Figure 49: Zimmer Biomet Holdings Inc. Financial Performance
  • Figure 50: Vericel Corporation Financial Performance
  • Figure 51: Stryker Corporation Financial Performance
  • Figure 52: Smith & Nephew plc Financial Performance
Global Heparin Market Size, Forecasts, And Opportunities – Includes Heparin Market Report
Global Generic Pharmaceuticals Market Outlook, Opportunities And Strategies – Includes Generic Pharmaceuticals Market Size
Global Hormonal Contraceptives Market Outlook, Opportunities And Strategies – Includes Hormonal Contraceptives Market Size
Global Immuno-Oncology Drugs Market Size, Forecasts, And Opportunities – Includes Immuno-Oncology Drugs Market Trends
Global Biosimilars Market Outlook, Opportunities And Strategies – Includes Biosimilars Vs Generic
Global Cancer Monoclonal Antibodies Market Size, Forecasts, And Opportunities – Includes Cancer Monoclonal Antibodies Market Share
Global Coronavirus (COVID-19) Current Therapy Market Outlook, Opportunities And Strategies – Includes Coronavirus (COVID-19) Current Therapy Market Analysis
Global Autoimmune Disease Diagnosis Market Size, Forecasts, And Opportunities – Includes Autoimmune Disease Diagnosis Market Analysis
3D Cell Culture Technologies Global Market Report 2022 – By Type (Scaffold-based, Scaffold-free, 3D Bioreactors), By End Users (Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users), By Scaffold-based (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates), By Scaffold-free (Hanging Drop Microplates, Spheroid Microplates, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022 – By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells), By Application (Academic Research, Drug Development And Discovery, Toxicity Screening, Regenerative Medicine), By End-User (Hospitals, Research Laboratories) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Stem Cell Global Market Report 2022 – By Source (Autologous, Allogeneic), By Product Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Others), By Application (Regenerative Medicine, Drug Discovery And Development) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Arthroscopy Devices And Equipment Global Market Report 2022 – By Product (Arthroscopes, Arthroscopy Shavers, Arthroscopy Fluid Management System, Arthroscopy Radiofrequency System, Arthroscopy Visualization System, Arthroscopy Implants), By Application (Knee Arthroscopy , Hip Arthroscopy , Spine Arthroscopy , Foot & Ankle Arthroscopy , Shoulder & Elbow Arthroscopy), By End User (Hospitals, Ambulatory Care, Trauma Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Joint Reconstruction Devices And Equipment Global Market Report 2022 – By Product Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Surgery, Osteotomy, Resurfacing Surgery, Small Joint Surgery), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cell Culture Consumables And Equipment Global Market Report 2022 – By Product (Consumables, Instruments), By End User (Industrial, Biotechnology, Agriculture, Other End Users), By Application (Vaccination, Toxicity Testing, Cancer Research, Drug Screening And Development, Recombinant Products, Stem Cell Technology, Regenerative Medicine), By Consumables (Media, Sera, Reagents), By Instruments (Cell Culture Vessels, Bioreactors, Biosafety Cabinets, Carbon Dioxide Incubators, Centrifuges) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Induced Pluripotent Stem Cell (iPSC) Market 2021 - By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic), By Application (Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Gene & Cell Therapy), By End-User (Hospitals, Research Laboratories) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Cell Culture Global Market Report 2022 – By Type (Primary Cell Culture, Secondary Cell Culture, Cell Line), By Media (Natural, Artificial), By Applications (Stem Cell Technologies, Cancer Research, Biopharmaceutical, Tissue Engineering And Regenerative Medicine) – Market Size, Trends, And Global Forecast 2022-2026
View Report